You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Seretide inhaler technique and safety

Seretide is available in both an aerosol (Evohaler) and a dry powder formulation (Accuhaler). The two different formulations are bioequivalent.[1]

When using a metered dose inhaler (MDI) either the Volumatic or AeroChamber Plus spacer device can be used (depending on National Guidance).[1] Limited data are available that demonstrate an increase in systemic exposure when the AeroChamber Plus spacer device is used compared with the Volumatic spacer device.[1] Patients should continue to use the same make of spacer device as switching devices can result in changes in the dose delivered to the lungs.[1] All healthcare professionals should be encouraged to assess asthma control, adherence and inhaler technique at every visit.[2]

Inhaler technique videos

How to use the Evohaler:

Video player requires JavaScript enabled. You can download this video here: https://gskvideo.edgesuite.net/HealthSites/Health/UK/MP4/Evohaler-video-2017.mp4

How to use the Evohaler with a spacer:

Video player requires JavaScript enabled. You can download this video here: https://gskvideo.edgesuite.net/HealthSites/Health/UK/MP4/Evohaler-Volumatic-video-2017.mp4

How to use the Accuhaler:

Video player requires JavaScript enabled. You can download this video here: https://gskvideo.edgesuite.net/HealthSites/Health/UK/MP4/Accuhaler-video-2017.mp4


Seretide safety

Very common adverse events:

Headache
Nasopharyngitis

Common adverse events:

Candidiasis of the mouth and throat
Pneumonia (in COPD patients)
Bronchitis
Hypokalaemia
Throat irritation
Hoarseness/dysphonia
Sinusitis
Contusions
Muscle cramps
Traumatic fractures
Arthralgia
Myalgia

For contraindications, special warnings and precautions for use please see:

Seretide Accuhaler Summary of Product Characteristics (last accessed - March 2017)

Seretide Evohaler Summary of Product Characteristics (last accessed – March 2017)

Seretide, Accuhaler and Evohaler are registered trademarks of the GlaxoSmithKline Group of Companies